New Antifungal Drugs, New Approaches and Vaccines

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)

Phase 2

15 May 2008

Study of Different Doses of a Novel Treatment for Onychomycosis

Phase 2

15 May 2008

Study of Different Doses of a Novel Treatment for Onychomycosis

Phase 2

20 February 2016

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

Phase 2

17 May 2008

Cumulative Irritation Test

Phase 1

8 May 2008

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

Phase 2

14 January 2011

Scynexis’ (SCYX) SCY-078 Receives FDA Fast Track and QIDP Designations

28 January 2016

Universal fungal vaccines: Could there be light at the end of the tunnel?

1 August 2012

Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens

1 December 2012

Whole Glucan Particles as a Vaccine Against Murine Aspergillosis.

6 October 2014